|
Market Closed -
Japan Exchange
12:00:00 19/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 6,403.00 JPY | +0.50% |
|
+0.79% | -19.39% |
Company Valuation: COSMOS Pharmaceutical Corporation
Data adjusted to current consolidation scope
| Fiscal Period: May | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,83,107 | 5,25,081 | 5,02,890 | 7,00,001 | 4,76,495 | 5,04,948 | - | - |
| Change | - | 8.69% | -4.23% | 39.2% | -31.93% | 5.97% | - | - |
| Enterprise Value (EV) 1 | 4,50,132 | 4,97,354 | 4,77,918 | 6,92,920 | 4,76,495 | 5,32,781 | 5,40,892 | 5,48,173 |
| Change | - | 10.49% | -3.91% | 44.99% | -31.23% | 11.81% | 1.52% | 1.35% |
| P/E | 20.9x | 22.1x | 20.6x | 22.6x | 14.9x | 15.8x | 15x | 14.2x |
| PBR | 2.54x | 2.49x | 2.17x | 2.72x | 1.68x | 1.64x | 1.51x | 1.39x |
| PEG | - | 7.98x | 7.61x | 0.8x | 4.32x | -56.28x | 2.7x | 2.7x |
| Capitalization / Revenue | 0.64x | 0.63x | 0.52x | 0.69x | 0.43x | 0.43x | 0.4x | 0.37x |
| EV / Revenue | 0.6x | 0.6x | 0.5x | 0.69x | 0.43x | 0.46x | 0.43x | 0.41x |
| EV / EBITDA | 10x | 10.5x | 9.29x | 11.1x | 7.12x | 7.54x | 7.17x | 6.85x |
| EV / EBIT | 15.1x | 16.5x | 15.2x | 17.1x | 11.3x | 12x | 11.6x | 11.1x |
| EV / FCF | -39.1x | 93.5x | -222x | -807x | -20.6x | -79.5x | -111x | -609x |
| FCF Yield | -2.56% | 1.07% | -0.45% | -0.12% | -4.85% | -1.26% | -0.9% | -0.16% |
| Dividend per Share 2 | 40 | 50 | 60 | 70 | 82 | 85.3 | 90.01 | 94.2 |
| Rate of return | 0.66% | 0.75% | 0.95% | 0.79% | 1.36% | 1.34% | 1.41% | 1.48% |
| EPS 2 | 292.4 | 300.5 | 308.6 | 390.9 | 404.3 | 403.2 | 425.6 | 448 |
| Distribution rate | 13.7% | 16.6% | 19.4% | 17.9% | 20.3% | 21.2% | 21.2% | 21% |
| Net sales 1 | 7,55,414 | 8,27,697 | 9,64,989 | 10,11,390 | 10,99,583 | 11,69,035 | 12,52,854 | 13,46,732 |
| EBITDA 1 | 44,906 | 47,496 | 51,425 | 62,633 | 66,929 | 70,661 | 75,423 | 79,995 |
| EBIT 1 | 29,796 | 30,128 | 31,501 | 40,404 | 42,353 | 44,227 | 46,702 | 49,285 |
| Net income 1 | 23,155 | 23,797 | 24,454 | 30,978 | 32,046 | 31,963 | 33,733 | 35,499 |
| Net Debt 1 | -32,975 | -27,727 | -24,972 | -7,081 | - | 27,833 | 35,944 | 43,225 |
| Reference price 2 | 6,100.00 | 6,630.00 | 6,345.00 | 8,832.00 | 6,012.00 | 6,371.00 | 6,371.00 | 6,371.00 |
| Nbr of stocks (in thousands) | 79,198 | 79,198 | 79,258 | 79,257 | 79,257 | 79,257 | - | - |
| Announcement Date | 11/07/22 | 10/07/23 | 12/07/24 | 11/07/25 | 13/07/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15.8x | 0.46x | 7.54x | 1.34% | 317.04Cr | ||
| 16.01x | 0.63x | 9.49x | -.--% | 1.42TCr | ||
| 19.15x | 0.88x | 8.94x | 1.98% | 731.64Cr | ||
| 23.15x | 0.4x | 6.18x | 1.95% | 703.89Cr | ||
| 18.85x | 0.67x | 11.61x | 1.54% | 563.47Cr | ||
| 17.15x | 1.07x | 7.65x | 2.63% | 484.4Cr | ||
| 16.52x | 0.73x | 7.78x | 2.45% | 421.3Cr | ||
| 15.58x | 0.69x | 5.7x | 4.58% | 353.61Cr | ||
| 18.52x | 0.39x | 6.15x | 1.24% | 329.13Cr | ||
| 14.95x | 1.26x | 7.99x | 5.88% | 330.06Cr | ||
| Average | 17.57x | 0.72x | 7.90x | 2.36% | 565Cr | |
| Weighted average by Cap. | 17.77x | 0.70x | 8.30x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3349 Stock
- Valuation COSMOS Pharmaceutical Corporation
Select your edition
All financial news and data tailored to specific country editions
















